恒瑞医药9月回购 457.24 万股A股 涉资约3.154亿元

Core Viewpoint - Heng Rui Medicine (600276) announced the progress of its A-share buyback, indicating a strategic move to enhance shareholder value through share repurchase [1] Buyback Details - The company repurchased a total of 4.5724 million shares through the Shanghai Stock Exchange, representing 0.07% of the total share capital [1] - The highest purchase price was RMB 70.00 per share, while the lowest was RMB 67.20 per share [1] - The total amount paid for the repurchased shares was approximately RMB 315.4 million, excluding transaction fees [1]